Literature DB >> 7639524

Short-chain 3-hydroxy-2-methylacyl-CoA dehydrogenase from rat liver: purification and characterization of a novel enzyme of isoleucine metabolism.

M J Luo1, L F Mao, H Schulz.   

Abstract

Short-chain L-3-hydroxy-2-methylacyl-CoA dehydrogenase (SC-HMAD), a soluble mitochondrial enzyme, was purified 6000-fold from rat liver in 6% yield by a six-step purification procedure. The purified enzyme was homogenous as judged by gel electrophoresis in the presence of sodium dodecyl sulfate. The molecular mass of this protein was estimated to be 28 kDa under denaturing conditions. Under nondenaturing conditions, the enzyme behaved on Sephacryl S-200 like serum albumin with a molecular mass of 66 kDa. Thus, SC-HMAD seems to be a dimer composed of two, most likely identical 28-kDa subunits. Immunoblotting with antibodies to pig heart L-3-hydroxyacyl-CoA dehydrogenase (HAD) (EC 1.1.1.35) revealed that SC-HMAD and HAD are immunologically unrelated proteins. SC-HMAD, but not HAD, catalyzes the NAD(+)-dependent dehydrogenation of L-3-hydroxy-2-methybutyryl-CoA, a metabolite of isoleucine, to 2-methylacetoacetyl-CoA. Relative activities with 3-hydroxy-2-methylacyl-CoA thioesters having acyl chains with 4, 5, 10, and 16 carbon atoms are 88, 100, 16, and 0%, respectively. Unbranched 3-hydroxyacyl-CoA thioesters are also substrates of SC-HMAD, although poorer ones as evidenced by apparent Km values of 5 and 19 microM for L-3-hydroxy-2-methylbutyryl-CoA and L-3-hydroxybutyryl-CoA, respectively. Maximal velocities observed with these two substrates were similar. It is concluded that SC-HMAD catalyzes the second dehydrogenation step during the beta-oxidation of the isoleucine metabolite 2-methylbutyryl-CoA. This enzyme may also be involved in the beta-oxidation of natural and xenobiotic branched chain carboxylic acids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639524     DOI: 10.1006/abbi.1995.1388

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

Review 1.  HSD10 disease: clinical consequences of mutations in the HSD17B10 gene.

Authors:  Johannes Zschocke
Journal:  J Inherit Metab Dis       Date:  2011-11-30       Impact factor: 4.982

2.  Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.

Authors:  P T Clayton; S Eaton; A Aynsley-Green; M Edginton; K Hussain; S Krywawych; V Datta; H E Malingre; R Berger; I E van den Berg
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

Authors:  R J Wanders; P Vreken; M E den Boer; F A Wijburg; A H van Gennip; L IJlst
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

4.  A novel HSD17B10 mutation impairing the activities of the mitochondrial RNase P complex causes X-linked intractable epilepsy and neurodevelopmental regression.

Authors:  Marni J Falk; Xiaowu Gai; Megumi Shigematsu; Elisa Vilardo; Ryuichi Takase; Elizabeth McCormick; Thomas Christian; Emily Place; Eric A Pierce; Mark Consugar; Howard B Gamper; Walter Rossmanith; Ya-Ming Hou
Journal:  RNA Biol       Date:  2016-03-07       Impact factor: 4.652

5.  Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism.

Authors:  Song-Yu Yang; Xue-Ying He; Simon E Olpin; Vernon R Sutton; Joe McMenamin; Manfred Philipp; Robert B Denman; Mazhar Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

6.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene.

Authors:  Rob Ofman; Jos P N Ruiter; Marike Feenstra; Marinus Duran; Bwee Tien Poll-The; Johannes Zschocke; Regina Ensenauer; Willy Lehnert; Jörn Oliver Sass; Wolfgang Sperl; Ronald J A Wanders
Journal:  Am J Hum Genet       Date:  2003-04-14       Impact factor: 11.025

7.  Purification, crystallization and preliminary crystallographic analysis of 3-hydroxyacyl-CoA dehydrogenase from Caenorhabditis elegans.

Authors:  Yingzhi Xu; Fei Sun
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-04-30

8.  A novel mutation in the HSD17B10 gene of a 10-year-old boy with refractory epilepsy, choreoathetosis and learning disability.

Authors:  Laurie H Seaver; Xue-Ying He; Keith Abe; Tina Cowan; Gregory M Enns; Lawrence Sweetman; Manfred Philipp; Sansan Lee; Mazhar Malik; Song-Yu Yang
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

9.  Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the human mitochondrial RNase P complex.

Authors:  Elisa Vilardo; Walter Rossmanith
Journal:  Nucleic Acids Res       Date:  2015-04-29       Impact factor: 16.971

10.  Dimerization interface of 3-hydroxyacyl-CoA dehydrogenase tunes the formation of its catalytic intermediate.

Authors:  Yingzhi Xu; He Li; Ying-Hua Jin; Jun Fan; Fei Sun
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.